Production de Pénicilline G par Fermentation

L'antibiotique qui a transformé la médecine moderne

Pharmaceutical & Drug Manufacturing Global Industrial Scale $1.8 billion

Aperçu

Penicillin G (benzylpenicillin) is produced by submerged aerobic fermentation of Penicillium chrysogenum in large-scale stirred-tank bioreactors. Since Alexander Fleming's 1928 discovery, industrial production has been refined to achieve yields over 50 g/L through strain improvement and process optimization. The fermentation typically runs for 6-8 days, followed by extraction, purification, and crystallization. Penicillin G serves as a direct therapeutic agent and as the starting material for semi-synthetic penicillins.

Procédé chimique

Penicillium chrysogenum is cultivated in 100,000-200,000 liter bioreactors with continuous feeding of glucose and phenylacetic acid as the side-chain precursor. The broth is filtered, extracted with butyl acetate at pH 2-2.5, and crystallized as the potassium salt.

L-Cysteine + L-Valine + Phenylacetic acid → Penicillin G (enzyme-catalyzed biosynthesis via ACV synthetase, isopenicillin N synthase, and acyltransferase)

Matières premières

  • Glucose (C₆H₁₂O₆) — Corn wet milling (Carbon source)
  • Phenylacetic acid (C₈H₈O₂) — Chemical synthesis (Side-chain precursor)
  • Corn steep liquor — Corn wet milling byproduct (Nitrogen source)

Produits finis

  • Penicillin G potassium — Injectable antibiotic and semi-synthetic penicillin precursor (>98% purity by HPLC)
  • 6-APA (6-aminopenicillanic acid) — Core structure for semi-synthetic penicillins (Derived by enzymatic cleavage)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation generates large volumes of mycelial waste and spent broth requiring treatment. Solvent extraction with butyl acetate produces VOC emissions. Modern facilities use solvent recovery and waste biomass composting to reduce environmental impact.

Considérations de sécurité

Innovations récentes

Metabolic engineering of Penicillium strains using CRISPR-Cas9 has further improved yields.
Continuous chromatography purification is replacing traditional solvent extraction to reduce chemical waste and improve product quality.

Échelle de production

30000

tonnes/an

$1.8 billion

valeur marchande

Plus dans Pharmaceutical & Drug Manufacturing

Frequently Asked Questions

What industry uses Production de Pénicilline G par Fermentation?
Production de Pénicilline G par Fermentation is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Production de Pénicilline G par Fermentation?
Penicillium chrysogenum is cultivated in 100,000-200,000 liter bioreactors with continuous feeding of glucose and phenylacetic acid as the side-chain precursor. The broth is filtered, extracted with butyl acetate at pH 2-2.5, and crystallized as the potassium salt.
What is the economic significance of Production de Pénicilline G par Fermentation?
Production de Pénicilline G par Fermentation has a market value of $1.8 billion and annual production of 30,000 tons.
What is the environmental impact of Production de Pénicilline G par Fermentation?
Fermentation generates large volumes of mycelial waste and spent broth requiring treatment. Solvent extraction with butyl acetate produces VOC emissions. Modern facilities use solvent recovery and waste biomass composting to reduce environmental impact.
What raw materials are used in Production de Pénicilline G par Fermentation?
The main raw materials include: Glucose (C₆H₁₂O₆), Phenylacetic acid (C₈H₈O₂), Corn steep liquor.